In the US, rates of invasive meningococcal infection have been declining since the late 1990s to a low of 0.11 cases in 100,000 people during 2015-2017.[7]Centers for Disease Control and Prevention. Meningococcal disease. Feb 2024 [internet publication].
https://www.cdc.gov/meningococcal/about/index.html
Most infections are caused by serogroups B, C, and Y.[8]MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease - United States, 1996-2015. Clin Infect Dis. 2018 Apr 3;66(8):1276-81.
https://academic.oup.com/cid/article/66/8/1276/4605281
http://www.ncbi.nlm.nih.gov/pubmed/29126310?tool=bestpractice.com
[9]Centers for Disease Control and Prevention. Meningococcal disease in other countries. Feb 2024 [internet publication].
https://www.cdc.gov/meningococcal/php/global
Reduced incidence of meningococcal disease has been linked to the introduction of meningococcal conjugate vaccines.[8]MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease - United States, 1996-2015. Clin Infect Dis. 2018 Apr 3;66(8):1276-81.
https://academic.oup.com/cid/article/66/8/1276/4605281
http://www.ncbi.nlm.nih.gov/pubmed/29126310?tool=bestpractice.com
Most infections are sporadic, but about 5% of infections occur as part of outbreaks, caused predominantly by serogroups B, C, and Y.[1]Rubis A, Schillie S. Chapter 8: meningococcal disease. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: Centers for Disease Control and Prevention; 2024. The increasing incidence of serogroup W infections in the US, Europe, and Australia has been associated with a hypervirulent clonal strain.[10]Moore AE, MacNeil JR, Wang X, et al. Emergence of localized serogroup W meningococcal disease in the United States - Georgia, 2006-2016. MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):894-7.
https://www.cdc.gov/mmwr/volumes/67/wr/mm6732a5.htm
http://www.ncbi.nlm.nih.gov/pubmed/30114000?tool=bestpractice.com
The highest rates of invasive infection are in children under 5 years of age, especially those under 1 year of age, with a second peak occurring in 11- to 24-year-olds and a third peak in people >65 years of age.[11]European Centre for Disease Prevention and Control. Invasive meningococcal disease - annual epidemiological report for 2018. Jun 2022 [internet publication].
https://www.ecdc.europa.eu/sites/default/files/documents/AER-Invasive-meningococcal-disease-2018.pdf
Infections in infants and children ages 1-5 are predominantly caused by serogroup B.[11]European Centre for Disease Prevention and Control. Invasive meningococcal disease - annual epidemiological report for 2018. Jun 2022 [internet publication].
https://www.ecdc.europa.eu/sites/default/files/documents/AER-Invasive-meningococcal-disease-2018.pdf